JP2025521083A5 - - Google Patents

Info

Publication number
JP2025521083A5
JP2025521083A5 JP2024566233A JP2024566233A JP2025521083A5 JP 2025521083 A5 JP2025521083 A5 JP 2025521083A5 JP 2024566233 A JP2024566233 A JP 2024566233A JP 2024566233 A JP2024566233 A JP 2024566233A JP 2025521083 A5 JP2025521083 A5 JP 2025521083A5
Authority
JP
Japan
Prior art keywords
group
hydrogen
compound according
alkyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024566233A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025521083A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/066601 external-priority patent/WO2023220541A1/en
Publication of JP2025521083A publication Critical patent/JP2025521083A/ja
Publication of JP2025521083A5 publication Critical patent/JP2025521083A5/ja
Pending legal-status Critical Current

Links

JP2024566233A 2022-05-10 2023-05-04 HPK1阻害剤としてのテトラヒドロピリド[3,4-d]ピリミジン化合物 Pending JP2025521083A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263340191P 2022-05-10 2022-05-10
US63/340,191 2022-05-10
US202263383190P 2022-11-10 2022-11-10
US63/383,190 2022-11-10
PCT/US2023/066601 WO2023220541A1 (en) 2022-05-10 2023-05-04 Tetrahydropyrido[3,4-d]pyrimidines compounds as hpk1 inhibitors

Publications (2)

Publication Number Publication Date
JP2025521083A JP2025521083A (ja) 2025-07-08
JP2025521083A5 true JP2025521083A5 (enExample) 2026-05-14

Family

ID=86688794

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024566233A Pending JP2025521083A (ja) 2022-05-10 2023-05-04 HPK1阻害剤としてのテトラヒドロピリド[3,4-d]ピリミジン化合物

Country Status (9)

Country Link
US (1) US20240025922A1 (enExample)
EP (1) EP4522618A1 (enExample)
JP (1) JP2025521083A (enExample)
CN (1) CN119546610A (enExample)
AU (1) AU2023267747A1 (enExample)
CA (1) CA3250387A1 (enExample)
IL (1) IL316818A (enExample)
TW (1) TW202400612A (enExample)
WO (1) WO2023220541A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025210407A1 (en) * 2024-04-01 2025-10-09 Merck Patent Gmbh (7-{1h,2h,3h-pyrido [2,3-b][1,4]oxazin-7-yl}-5h,6h,7h,8h-pyrido[3,4-d]pyrimidin-2-yl)amine derivatives as bifunctional degraders of hpk1 for the treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019010302A (es) * 2017-03-30 2019-11-21 Hoffmann La Roche Isoquinolinas como inhibidores de hpk1.

Similar Documents

Publication Publication Date Title
JP2021521200A5 (enExample)
JP7673041B2 (ja) 治療薬としての細胞毒素のペプチドコンジュゲート
CN107089985B (zh) 作为詹纳斯相关激酶(jak)抑制剂的吡咯并[2,3-d]嘧啶衍生物
JP2021508686A5 (enExample)
HRP20130935T1 (hr) Bicikliäśki derivat aminokiseline
JP2011527686A5 (enExample)
JP2021534108A5 (enExample)
KR20120085738A (ko) 야누스 키나제 억제제로서의 피롤로 [1,2-b] 피리다진 유도체
TW200838497A (en) Sphingosine-1-phosphate receptor agonist and antagonist compounds
JP2009521494A5 (enExample)
TW200526567A (en) Prostaglandin derivatives
JP2021102643A5 (enExample)
JP2024536863A (ja) イミダゾピリダジンil-17阻害剤化合物
EP2282981A1 (en) {f-19} -labeled l-glutamic acid and l-glutamine derivative (iii), use thereof and method for obtaining them
ES2327250T3 (es) Derivados de amino-propanol.
JP2022523355A5 (enExample)
JP2012520321A5 (enExample)
JP2019529460A5 (enExample)
CN111511745A (zh) 吡唑并[1,5-a][1,3,5]三嗪-2-胺类衍生物、其制备方法及其在医药上的应用
CN109956986A (zh) 肝递送吉西他滨前体药物核苷环磷酸酯化合物及应用
CN111518077A (zh) 一种新型抗肿瘤ido抑制剂的制备方法
TWI638825B (zh) 抑制癌症及病毒之化合物
JP2023510865A5 (enExample)
WO2021110010A1 (zh) 新型吡咯化合物
JP2025509830A5 (enExample)